4.4 Article

Influenza-Induced Inflammation Drives Pneumococcal Otitis Media

Journal

INFECTION AND IMMUNITY
Volume 81, Issue 3, Pages 645-652

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/IAI.01278-12

Keywords

-

Funding

  1. GlaxoSmithKline
  2. Elizabeth and Vernon Puzey postgraduate research scholarship
  3. European Commission [08010]
  4. Australian National Health and Medical Research Council
  5. Australian Government Department of Health and Ageing
  6. University of Melbourne Overseas Research Scholarship, a Boehringer-Ingelheim Fonds Travel grant
  7. EMBO Short-Term Research fellowship

Ask authors/readers for more resources

Influenza A virus (IAV) predisposes individuals to secondary infections with the bacterium Streptococcus pneumoniae (the pneumococcus). Infections may manifest as pneumonia, sepsis, meningitis, or otitis media (OM). It remains controversial as to whether secondary pneumococcal disease is due to the induction of an aberrant immune response or IAV-induced immunosuppression. Moreover, as the majority of studies have been performed in the context of pneumococcal pneumonia, it remains unclear how far these findings can be extrapolated to other pneumococcal disease phenotypes such as OM. Here, we used an infant mouse model, human middle ear epithelial cells, and a series of reverse-engineered influenza viruses to investigate how IAV promotes bacterial OM. Our data suggest that the influenza virus HA facilitates disease by inducing a proinflammatory response in the middle ear cavity in a replication-dependent manner. Importantly, our findings suggest that it is the inflammatory response to IAV infection that mediates pneumococcal replication. This study thus provides the first evidence that inflammation drives pneumococcal replication in the middle ear cavity, which may have important implications for the treatment of pneumococcal OM.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

Jan-Stephan F. Sanders, Frederike J. Bemelman, A. Lianne Messchendorp, Carla C. Baan, Debbie van Baarle, Rob van Binnendijk, Dimitri A. Diavatopoulos, Sophie C. Frolke, Daryl Geers, Corine H. GeurtsvanKessel, Gerco den Hartog, Marieke van der Heiden, Celine Imhof, Marcia M. L. Kho, Marion P. G. Koopmans, S. Reshwan K. Malahe, Wouter B. Mattheussens, Renate van der Molen, Djenolan van Mourik, Ester B. M. Remmerswaal, Nynke Rots, Priya Vart, Rory D. de Vries, Ron T. Gansevoort, Luuk B. Hilbrands, Marlies E. J. Reinders

Summary: In kidney patients, the immunogenicity, tolerability, and safety of COVID-19 vaccination vary. Kidney transplant recipients have a poor immune response, while patients with CKD G4/5 and those on dialysis have a comparable response to the control group. Dialysis patients and transplant recipients experience fewer adverse events after vaccination.

TRANSPLANTATION (2022)

Article Immunology

BCG-induced trained immunity enhances acellular pertussis vaccination responses in an explorative randomized clinical trial

Joshua Gillard, Bastiaan A. Blok, Daniel R. Garza, Prashanna Balaji Venkatasubramanian, Elles Simonetti, Marc J. Eleveld, Guy A. M. Berbers, Pieter G. M. van Gageldonk, Irma Joosten, Ronald de Groot, L. Charlotte J. de Bree, Reinout van Crevel, Marien de Jonge, Martijn A. Huynen, Mihai G. Netea, Dimitri A. Diavatopoulos

Summary: This study demonstrates that prior Bacille Calmette-Guerin (BCG) vaccination enhances immune responses to pertussis vaccines. Simultaneous BCG and acellular pertussis (aP) vaccinations do not show the same effect. Biomarkers of trained immunity are identified as the most reliable correlates of the enhanced immune responses.

NPJ VACCINES (2022)

Article Virology

Mouse Mx1 Inhibits Herpes Simplex Virus Type 1 Genomic Replication and Late Gene Expression In Vitro and Prevents Lesion Formation in the Mouse Zosteriform Model

Melkamu B. Tessema, Rubaiyea Farrukee, Christopher E. Andoniou, Mariapia A. Degli-Esposti, Clare Oates, James B. Barnes, Linda M. Wakim, Andrew G. Brooks, Sarah L. Londrigan, Patrick C. Reading

Summary: This study is the first to report the antiviral activity of mouse Mx1 against alphaherpesviruses, demonstrating that mMx1 can effectively inhibit the growth of HSV-1 by blocking viral genome replication and late gene expression. Additionally, the functional endogenous mMx1 is shown to limit the pathogenesis of HSV-1 in a mouse infection model.

JOURNAL OF VIROLOGY (2022)

Article Multidisciplinary Sciences

SARS-CoV-2 RNA in exhaled air of hospitalized COVID-19 patients

Lisa Kurver, Corne H. van den Kieboom, Kjerstin Lanke, Dimitri A. Diavatopoulos, Gijs J. Overheul, Mihai G. Netea, Jaap ten Oever, Reinout van Crevel, Karin Mulders-Manders, Frank L. van de Veerdonk, Heiman Wertheim, Jeroen Schouten, Janette Rahamat-Langendoen, Ronald P. van Rij, Teun Bousema, Arjan van Laarhoven, Marien de Jonge

Summary: Understanding the contagiousness of COVID-19 is crucial for the accurate management of hospitalized patients. This study found that in addition to droplet transmission, aerosolized SARS-CoV-2 also contributes to the spread of infection. Using a disposable modular breath sampler, the researchers successfully detected viral RNA in exhaled air samples from 25% of the hospitalized COVID-19 patients.

SCIENTIFIC REPORTS (2022)

Article Immunology

Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

Jan Stephan F. Sanders, A. Lianne Messchendorp, Rory D. de Vries, Carla C. Baan, Debbie van Baarle, Rob van Binnendijk, Dimitri A. Diavatopoulos, Daryl Geers, Katharina S. Schmitz, Corine H. GeurtsvanKessel, Gerco den Hartog, Marcia M. L. Kho, Marion P. G. Koopmans, Renate G. van der Molen, Ester B. M. Remmerswaal, Nynke Rots, Ron T. Gansevoort, Frederike J. Bemelman, Luuk B. Hilbrands, Marlies E. J. Reinders

Summary: The immune response to COVID-19 vaccination is inferior in kidney transplant recipients and to a lesser extent in patients on dialysis or with chronic kidney disease. The antibody levels and T-cell responses significantly decrease after 6 months of vaccination, and neutralization of the Omicron variant is barely detectable.

CLINICAL INFECTIOUS DISEASES (2023)

Article Virology

Expression of a Functional Mx1 Protein Is Essential for the Ability of RIG-I Agonist Prophylaxis to Provide Potent and Long-Lasting Protection in a Mouse Model of Influenza A Virus Infection

Lara S. U. Schwab, Fernando Villalon-Letelier, Melkamu B. Tessema, Sarah L. Londrigan, Andrew G. Brooks, Aeron Hurt, Christoph Coch, Thomas Zillinger, Gunther Hartmann, Patrick C. Reading

Summary: The synthetic RIG-I agonist can induce the expression of interferon-stimulated genes (ISGs) and inhibit IAV infection in mice, but the effectiveness varies between mouse strains with or without functional Mx1 expression.

VIRUSES-BASEL (2022)

Article Infectious Diseases

Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial

Marcia M. L. Kho, A. Lianne Messchendorp, Sophie C. Froelke, Celine Imhof, Vera J. C. H. Koomen, S. Reshwan K. Malahe, Priya Vart, Daryl Geers, Rory D. de Vries, Corine H. Geurtsvan Kessel, Carla C. Baan, Renate G. van der Molen, Dimitri A. Diavatopoulos, Ester B. M. Remmerswaal, Debbie van Baarle, Rob van Binnendijk, Gerco den Hartog, Aiko P. J. de Vries, Ron T. Gansevoort, Frederike J. Bemelman, Marlies E. J. Reinders, Jan-Stephan F. Sanders, Luuk B. Hilbrands

Summary: This study aimed to compare three alternative strategies for improving the COVID-19 vaccine response in kidney transplant recipients: double vaccine dose, heterologous vaccination, and temporary discontinuation of mycophenolate mofetil or mycophenolic acid. The results showed that repeated vaccination increased SARS-CoV-2-specific antibodies in kidney transplant recipients, but higher dose, heterologous vaccine, or discontinuation of immunosuppressants did not further enhance the response.

LANCET INFECTIOUS DISEASES (2023)

Article Biochemistry & Molecular Biology

Pathway and Network Analyses Identify Growth Factor Signaling and MMP9 as Potential Mediators of Mitochondrial Dysfunction in Severe COVID-19

Ya Wang, Klaus Schughart, Tiana Maria Pelaia, Tracy Chew, Karan Kim, Thomas Karvunidis, Ben Knippenberg, Sally Teoh, Amy L. Phu, Kirsty R. Short, Jonathan Iredell, Irani Thevarajan, Jennifer Audsley, Stephen Macdonald, Jonathon Burcham, Benjamin Tang, Anthony McLean, Maryam Shojaei

Summary: Compared to healthy individuals and patients with mild/moderate COVID-19, severe COVID-19 patients showed upregulation of growth factor and cell cycle signaling pathways, with downregulation of interferon signaling pathways. Matrix metallopeptidase 9 (MMP9) was found in five of the top 10 upregulated pathways, indicating its potential as a therapeutic target against COVID-19.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Immunology

A semi high-throughput whole blood-based flow cytometry assay to detect and monitor Bordetella pertussis-specific Th1, Th2 and Th17 responses

Veronique Corbiere, Eleonora E. Lambert, Marine Rodesch, Jacqueline A. M. van Gaans-van den Brink, Alicja Misiak, Elles Simonetti, Anne Van Praet, Audrey Godefroid, Dimitri A. Diavatopoulos, Cecile A. C. M. van Els, Francoise Mascart

Summary: This study developed a two-step assay for evaluating the immunogenicity of pertussis vaccines. It involved stimulating fresh whole blood with pertussis antigens, cryopreserving the stimulated cells, and later analyzing cytokine production using flow cytometry. The assay demonstrated high reproducibility and sensitivity, allowing for the accurate quantification of pertussis antigen-specific Th1, Th2, and Th17-type CD4(+) T cells.

FRONTIERS IN IMMUNOLOGY (2023)

Editorial Material Immunology

Mammalian infections with highly pathogenic avian influenza viruses renew concerns of pandemic potential

Brad Gilbertson, Kanta Subbarao

Summary: There is a widespread and unprecedented spread of highly pathogenic avian influenza A H5N1 viruses in bird species on five continents, with infections also reported in mammals, most likely caused by consuming infected birds. The increase in H5N1 virus infections in different species could lead to the emergence of new viral variants that may adapt to mammals and potentially humans. It is crucial to monitor and assess the presence of mutations in mammalian-origin H5N1 clade 2.3.4.4b viruses that could increase their risk for human pandemics. Although there have been a limited number of human cases so far, the infection of mammals provides opportunities for the virus to acquire mutations that enhance infection, replication, and spread in mammals, which were not observed in the past viruses.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Article Virology

Genome evolution of dengue virus serotype 1 under selection by Wolbachia pipientis in Aedes aegypti mosquitoes

Duong Thi Hue Kien, Kathryn Edenborough, Daniela da Silva Goncalves, Tran Thuy Vi, Etiene Casagrande, Huynh Thi Le Duyen, Vo Thi Long, Le Thi Dui, Vu Thi Tuyet Nhu, Nguyen Thi Giang, Huynh Thi Xuan Trang, Elvina Lee, I'ah Donovan-Banfield, Huynh Thi Thuy Van, Nguyen Minh Nguyet, Nguyen Thanh Phong, Nguyen Van Vinh Chau, Bridget Wills, Sophie Yacoub, Heather Flores, Cameron Simmons

Summary: The introgression of antiviral strains of Wolbachia into Aedes aegypti mosquito populations is a public health intervention for the control of dengue. However, the study found that the dengue virus (DENV) could evolve to bypass the antiviral effects of Wolbachia. The experiment showed that the wMel strain of Wolbachia can select for a specific amino acid substitution in the DENV-1 envelope protein.

VIRUS EVOLUTION (2023)

Article Microbiology

Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity

Tina Meischel, Svenja Fritzlar, Fernando Villalon-Letelier, Jeffrey M. Smith, Andrew G. Brooks, Patrick C. Reading, Sarah L. Londrigan

Summary: Ectopic protein overexpression is commonly used to screen host factors' antiviral activity, but its relevance to endogenous protein function remains unclear. In this study, we demonstrate that constitutive overexpression of IFITMs significantly restricts parainfluenza virus-3 infection in A549 cells. We also observe variable mRNA and protein expression levels for IFITMs with constitutive overexpression compared to inducible overexpression. These findings highlight the limitations of overexpression approaches in studying antiviral activity and suggest caution in attributing the function of endogenous proteins.

PATHOGENS (2023)

Article Microbiology

TRIM16 Overexpression in HEK293T Cells Results in Cell Line-Specific Antiviral Activity

Lance R. R. Nigos, Nichollas E. E. Scott, Andrew G. G. Brooks, Malika Ait-Goughoulte, Sarah L. L. Londrigan, Patrick C. Reading, Rubaiyea Farrukee

Summary: Host cell restriction factors are intracellular proteins that can inhibit virus replication. In this study, TRIM16 was investigated as a potential host cell restriction factor. Overexpression of TRIM16 in HEK293T cells resulted in inhibition of multiple viruses, but alternative approaches did not validate these findings.

PATHOGENS (2023)

Article Virology

Role of the viral polymerase during adaptation of influenza A viruses to new hosts

Brad Gilbertson, Melanie Duncan, Kanta Subbarao

Summary: This review discusses the crucial role of viral polymerase in host adaptation of influenza A viruses (IAV), focusing on the interactions between viral polymerase genes and host factors. The known viral mutations and the adaptation of avian IAV to mammalian hosts are also highlighted.

CURRENT OPINION IN VIROLOGY (2023)

Article Virology

What HaveWe Learned by Resurrecting the 1918 Influenza Virus?

Brad Gilbertson, Kanta Subbarao

Summary: This article discusses the advances made by resurrecting the 1918 virus, including the rise of innovative molecular research.

ANNUAL REVIEW OF VIROLOGY (2023)

No Data Available